One of my favorite Emerging Growth stocks, Illumina (ILMN) is surging higher in today's trading. The company is involved in genetic testing and its business has been red-hot lately (here's a great profile of Illumina from Wall Strip).
Illumina reported fourth-quarter earnings of 22 cents a share and sales jumped 43% to $160.9 million. That was far higher than Wall Street's consensus which was looking for earnings of 17 cents a share and sales of $154.6 million. continued
by Louis Navellier | 02/09/09 | Stocks: ILMN,
![]() |
![]() |
|
|
||
![]() |
![]() |
Subscribe to our RSS feed and you will receive all the articles by InvestorPlace Blogs contributors. Each contributor has their own RSS feed on their blog if you want to just follow specific people.